Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-23

Clinical Trial Update: Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut [NA]

View source ↗

Summary

A pilot trial evaluated whether adding raltegravir, with or without a second drug, affects HIV levels in the gut. The study is completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Raltegravir (raltegravir)

Snippet

Sponsor: University of California, San Francisco | Conditions: HIV Infections | NA | Status: COMPLETED | Results posted: 2012-07-23